In MS, the majority of monocytes display a classical (inflammatory) phenotype based on high CD40, CD86, HLA-DR, CD64 and CCR2 expression [19] and active MS lesions are dominated by monocyte-derived macrophages that have entered the CNS by traversing the blood–brain barrier (BBB). Here, CCR2 is linked to myeloid sarcoma.